|
|
|
General Information
Cell Culture Engineering XI
April 13-18, 2008
Hyatt Regency Coolum
Sunshine Coast, Queensland, Australia
About This Conference
This conference is oversubscribed. Execute the Waiting List Request Form if you would like to be placed on the waiting list.
Poster Dimensions 1.2m X 2.4m
Since the 1980s, animal cell culture technology has become essential for the production of an ever-increasing number of human and veterinary biopharmaceuticals. These bi-annual Cell Culture Engineering conferences are a leading venue for the academic, industrial and regulatory communities to learn and debate new concepts and issues related to animal cell culture research and development. The 11th anniversary of this highly successful conference series will be held at the top-ranked Hyatt Regency Coolum on the Sunshine coast of Australia. http://coolum.regency.hyatt.com
This 2008 meeting will celebrate our conference tradition of high quality and relevance to both industrial and academic participants, with topics ranging from the frontiers of fundamental science to the engineering challenges of cell culture process development.
Conference Attendance by Invitation Only
Attendance will be limited and by invitation only. For effective interactions of all participants, the conference will be limited to about 350 attendees. Invitations will be based on participation in oral and poster sessions, workshops or other contributions to the conference.
If you wish an invitation to attend, please complete and return the attached Application Form as soon as possible and no later than November 1, 2007.
Oral Sessions (click on title to see session descriptions)
- Engineering Host Cells and Vectors
Session Chairs: Martin Fussenegger (ETH, Switzerland) and Martin Sinacore (Wyeth BioPharma, USA)
- Accelerating Cell Line Development and Optimization
Session Chairs: Gyun Min Lee (KAIST, Korea) and Georg Schmid (Hoffman-La Roche, Switzerland)
-
Systems Biotechnology "-omics" in Process Productivity
Session Chairs: Dana Andersen (Genentech, USA) and Kelvin Lee (Cornell University, USA)
- Product Quality: Impact of Sequence and Process on Final Product
Session Chairs: Anton Middleberg (University of Queensland, Australia) and Pranhitha Reddy (Amgen, USA)
- Cell Culture Process Development and Scale-up: Challenges and Case Studies
Session Chairs: Charles Goochee (J&J/GBSC, USA) and Weichang Zhou (PDL BioPharma, USA)
-
Process Integration: Paradigms for Linking Cell Culture and Downstream Processing
Session Chairs: Robert Kiss (Genentech, USA) and Nigel Titchener-Hooker (University College London, UK)
-
Cell Culture for Viral Production
Session Chairs: Amine Kamen (National Research Council, Canada) and John Aunins (Merck, USA)
-
Novel Cell Lines for Transient and Stable Protein Expression - Options for Increased Productivity
Session Chairs: David James (University of Sheffield, UK) and Elke Lullau (AstraZeneca, Sweden)
-
Stem Cell Culture & Tissue Engineering
Session Chairs: Timothy Allsopp (Stem Cell Sciences, UK) and Jamie Piret (University of British Columbia, Canada)
Workshop Sessions (If highlighted, click on title to see session descriptions.)
Overall Workshop Chairs: Michael Butler (University of Manitoba, Canada) and Thomas Seewoester (Amgen, USA)
- 1A. Globalization of Cell Culture
Session Chairs: Miranda Yap (Bioprocessing Technology Institute, Singapore) and Liangzhi Xie (Sinocelltech, China)
- 1B. Cell Line Stability and Heterogeneity
Session Chairs: Tim Charlebois (Wyeth, USA) and Hansjoerg Hauser (Helmholtz Institute, Germany)
- 1C. Challenges During Production Process Scale-Up or Technology Transfer
Session Chairs: Alvin Nienow (University of Birmingham, UK) and Steve Lee (Bristol-Myers Squibb, USA)
- 2A. Single-Use Technologies for Cell Culture
Session Chairs: Sadettin Ozturk (Centocor, USA) and Russell Wong (Bayer Healthcare, USA)
- 2B. Scale-down Models for Successful Approvals and Post-Approval Changes
Session Chairs: Steve Meier (Genentech, USA) and Craig Zupke (Amgen, USA)
- 2C. Automation and Robotics in Cell Culture Process Development
Session Chairs: Thomas Seewoester (Amgen, USA) and Lin Zhang (Pfizer, USA)
Poster Sessions
Overall Chair: Laura Palomares (UNAM, Mexico)
Co-Chairs: Susan Casnocha (Pfizer, USA), Sherry Gu (Eli Lilly, USA), and William Miller (Northwestern University, USA)
Poster Dimensions 1.2m X 2.4m
Publication of Abstracts
Abstracts of presentations will be published in the conference program, available
to all participants at the time of the conference.
Merck Award
The Merck Cell Culture Engineering Award recognizes an outstanding contributor to the field of Cell Culture Technology & Engineering and significant service and dedication to the profession. Martin Fussenegger is the recipient of the
2008 Award. See Announcement.
[ Go to top ]
|